Andrew Ortega-Verdaguer, IntelVasc Inc. episode artwork

EPISODE · Jan 14, 2025 · 31 MIN

Andrew Ortega-Verdaguer, IntelVasc Inc.

from Global Trial Accelerators™: Fast-Tracking First-in-Human Trials, Anywhere · host Julio G. Martinez-Clark

Today, we have the privilege of speaking with Andrew, a distinguished leader with over 15 years of international experience in marketing, commercial excellence, and business strategy. Throughout his career, he has led large teams at top pharmaceutical and medical device companies, including Novartis, Terumo, and Penumbra Inc. Andrew is a proud graduate of the IGNITE Program at Stanford Graduate School of Business and has also studied at several other prestigious international business schools. His expertise and journey in medical innovation make him a key voice in understanding the challenges and opportunities within the industry. 

Episode metadata supplied by the publisher feed · Published Jan 14, 2025

Embed this episode

NOW PLAYING

Andrew Ortega-Verdaguer, IntelVasc Inc.

0:00 31:28

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Global Trial Accelerators™: Fast-Tracking First-in-Human Trials, Anywhere?

This episode is 31 minutes long.

When was this Global Trial Accelerators™: Fast-Tracking First-in-Human Trials, Anywhere episode published?

This episode was published on January 14, 2025.

Is there a transcript available for this episode?

Yes, a full transcript is available for this episode. You can read the complete transcript on the episode page.

Can I download this Global Trial Accelerators™: Fast-Tracking First-in-Human Trials, Anywhere episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!